Development and validation of a bleeding risk prediction score for patients with mitral valve stenosis and atrial fibrillation or mechanical heart valves receiving long‐term warfarin therapy — Sararat Phetroong (2022) | RDL Network
Development and validation of a bleeding risk prediction score for patients with mitral valve stenosis and atrial fibrillation or mechanical heart valves receiving long‐term warfarin therapy
Article 2022 en
Authors
SP
Sararat Phetroong
SN
Surakit Nathisuwan
BC
Busba Chindavijak
Abstract
1 min read
The HEARTS-60 + 3 score shows a potential as a bleeding risk prediction score in MSAF or MHV patients.
Felice Gragnano, Dik Heg, Anna Franzone, Eugène McFadden, Sergio Leonardi, Raffaele Piccolo, Pascal Vranckx, Mattia Branca, Patrick W. Serruys, Edouard Benit, Christoph Liebetrau, Luc Janssens, Maurizio Ferrario, Aleksander Żurakowski, Roberto Diletti, Marcello Dominici, Kurt Huber, Ton Slagboom, Paweł Buszman, Leonardo Bolognese, Carlo Tumscitz, Krzysztof Bryniarski, Adel Aminian, Mathias Vrolix, Ivo Petrov, Scot Garg, Christoph Naber, Janusz Prokopczuk, Christian Hamm, Philippe Gabríel Steg, Peter Jüni, Stephan Windecker, Marco Valgimigli
European Heart Journal - Cardiovascular Pharmacotherapy
Discussion(0)
No comments yet. Be the first to comment.